**Core Concept**
Oral contraceptive pills (OCPs) are estrogen-containing agents that require normal hepatic metabolism for their activation and clearance. Impaired liver function disrupts the metabolism of hormones, increasing the risk of adverse effects such as thromboembolism and altered drug levels.

**Why the Correct Answer is Right**
Estrogen in combined oral contraceptives is metabolized primarily in the liver. In patients with impaired liver function, this metabolic pathway is compromised, leading to elevated estrogen levels and increased risk of venous thromboembolism. The liver also plays a key role in the clearance of the progestin component, further amplifying the risk. Thus, impaired liver function constitutes an **absolute contraindication** due to uncontrolled hormonal exposure and heightened thrombotic risk.

**Why Each Wrong Option is Incorrect**
Option A: Diabetes is not an absolute contraindication. Women with type 1 or type 2 diabetes can use OCPs safely, especially with proper monitoring, though risk of cardiovascular events may be higher.
Option B: Hypertension in young women is not an absolute contraindication. OCPs may elevate blood pressure slightly, but it's manageable with monitoring and lifestyle changes.
Option C: Obesity increases risk of thromboembolism, but it is not an absolute contraindication. OCPs can be used with caution and monitoring in overweight individuals.

**Clinical Pearl / High-Yield Fact**
Estrogen-containing contraceptives should be avoided in patients with **severe hepatic impairment** (e.g., cirrhosis, active liver failure) because the liver cannot metabolize hormones effectively — this is a well-established absolute contraindication.

✓ Correct Answer: D. Impaired liver function